NDC 42292-028-01 - Sulfamethoxazole and Trimethoprim
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 42292-028
- Requested NDC
- 42292-028-01
- Package NDCs from labels
- 42292-028-01, 42292-028-08
- Manufacturer
- Mylan Institutional Inc.
- Effective date
- 2019-11-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Sulfamethoxazole and Trimethoprim Tablets, USP | Mylan Institutional Inc. | 2019-11-07 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 42292-028-01 | EA - Each | 42292-028 | 82d7d58a-f7df-454e-8242-7401b0345200 | 1 | 2016-12-07 |
| 42292-028-08 | EA - Each | 42292-028 | 82c38478-2a7a-47f8-9fc7-c8b627d74c22 | 1 | 2016-12-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Senna-S | SENNOSIDES AND DOCUSATE SODIUM | Meijer, Inc. | 2619be6e-877b-16a2-e063-6394a90a68da | 2025-03-24 | Warnings | F05Q2T2JA0 |
| Stool Softener plus Stimulant Laxative | DOCUSATE SODIUM AND SENNOSIDES | Meijer, Inc. | 261a88d6-87d2-7544-e063-6294a90a2e94 | 2025-03-24 | Warnings | F05Q2T2JA0 |
| CVS Health Stool Softener Plus stimulant laxative Softgel | DOCUSATE SODIUM, SENNOSIDES | CVS Pharmacy, Inc | 2881d83d-9929-677a-e063-6394a90a0424 | 2025-03-19 | Warnings | F05Q2T2JA0 |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | Aurobindo Pharma Limited | 284b5dac-2b8d-46bf-95fe-80ce03fa178a | 2025-03-12 | Warnings, Adverse reactions | ANDA090624 65862-420 198334 198335 e4ea8e99-58d4-4c1b-b84c-db0838610059 284b5dac-2b8d-46bf-95fe-80ce03fa178a AN164J8Y0X JE42381TNV |
| Addiclenz | ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM, ARSENICUM ALBUM, BETA VULGARIS, BISPHENOL A, BOLDO, CHELIDONIUM MAJUS, COBALTUM METALLICUM, CUPRUM METALLICUM, GLYPHOSATE, IODIUM, LYCOPODIUM CLAVATUM, PETROSELINUM SATIVUM, PHOSPHORICUM ACIDUM, SELENIUM METALLICUM, TARAXACUM OFFICINALE, ZINCUM METALLICUM | Deseret Biologicals, Inc. | 25036c26-1c21-4e5a-b4db-b8e177458341 | 2025-03-11 | Warnings | OJ245FE5EU |
| SULFATRIM | SULFAMETHOXAZOLE AND TRIMETHOPRIM | PAI Holdings, LLC dba PAI Pharma | c62086ea-ba15-40f5-8431-4639c60c9825 | 2025-03-06 | Warnings, Adverse reactions | AN164J8Y0X JE42381TNV |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | A-S Medication Solutions | 8c74ea5c-d05e-4fc1-b980-aacaab56d472 | 2025-02-26 | Warnings, Adverse reactions | ANDA090624 198335 AN164J8Y0X JE42381TNV |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | A-S Medication Solutions | 20054147-811c-471a-8ec4-1b2903fe906e | 2025-02-26 | Warnings, Adverse reactions | ANDA090624 198335 AN164J8Y0X JE42381TNV |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | A-S Medication Solutions | a12fb7b0-9ff5-48f1-8fd9-4fbdfdbe09bc | 2025-02-26 | Warnings, Adverse reactions | ANDA090624 198335 AN164J8Y0X JE42381TNV |
| Sulfamethoxazole and Trimethoprim | SULFAMETHOXAZOLE AND TRIMETHOPRIM | Amneal Pharmaceuticals of New York LLC | 3233c54d-484d-4550-b172-db8af47d1b7f | 2025-02-26 | Warnings, Adverse reactions | 198334 198335 AN164J8Y0X JE42381TNV |
| Se-Natal 19 | .BETA.-CAROTENE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, THIAMINE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CYANOCOBALAMIN, CALCIUM PANTOTHENATE, CALCIUM CARBONATE, FERROUS FUMARATE, ZINC OXIDE AND DOCUSATE SODIUM | Seton Pharmaceuticals | 635104e6-6a53-4684-ac9a-7ac31b33083d | 2025-02-24 | Boxed warning, Warnings, Adverse reactions | F05Q2T2JA0 |
| SODIUM PHENYLACETATE and SODIUM BENZOATE | SODIUM PHENYLACETATE AND SODIUM BENZOATE | Omnivium Pharmaceuticals LLC | 9067c301-74f9-457a-9b0f-b7e9b06a3508 | 2025-02-15 | Warnings, Adverse reactions | OJ245FE5EU |
| Stool Softener and Stimulant Laxative | DOCUSATE SODIUM, SENNOSIDES | H-E-B | c19280c2-f968-b582-e053-2995a90a9bd3 | 2025-02-14 | Warnings | F05Q2T2JA0 |
| STOOL SOFTENER-STIMULANT LAXATIVE | STOOL SOFTENER-STIMULANT LAXATIVE | Kroger Company | a22c9f95-e3a9-bfd3-e053-2995a90a3c66 | 2025-02-13 | Warnings | F05Q2T2JA0 |
| SENNA-S | DOCUSATE SODIUM AND SENNOSIDES | KROGER | a187045c-c9d6-592a-e053-2995a90adb83 | 2025-02-10 | Warnings | F05Q2T2JA0 |
| SENNA TIME S | DOCUSATE SODIUM-SENNOSIDES | TIME CAP LABORATORIES, INC | dc491692-8d3a-4ccd-a17d-4c630f122595 | 2025-02-08 | Warnings | F05Q2T2JA0 |
| SENNOSIDES AND DOCUSATE SODIUM | SENNOSIDES AND DOCUSATE SODIUM | TIME CAP LABORATORIES, INC | 0ad617e0-10a6-44fa-be62-4f3cc725fb01 | 2025-02-08 | Warnings | F05Q2T2JA0 |
| Sennosides and Docusate Sodium | SENNOSIDES, DOCUSATE SODIUM | Asclemed USA, Inc. | 2db546de-20dc-4697-aff2-12471f073b1d | 2025-02-08 | Warnings | F05Q2T2JA0 |
| Docusate Sodium | DOCUSATE SODIUM | PAI Holdings, LLC dba PAI Pharma | e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5 | 2025-02-06 | Warnings | F05Q2T2JA0 |
| Docusate Sodium | DOCUSATE SODIUM | PD-Rx Pharmaceuticals, Inc. | 6a7e4193-22d2-491e-9842-5c43f571fc65 | 2025-02-05 | Warnings | F05Q2T2JA0 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.